Literature DB >> 8558078

Metabolism of deuterium-labeled linoleic, 6,9,12-octadecatrienoic, 8,11,14-eicosatrienoic, and arachidonic acids in the rat.

D L Luthria1, H Sprecher.   

Abstract

Male weanling rats were fed a diet that contained 2.1% ethyl oleate, 1% ethyl linoleate, and 0.2% ethyl linolenate. After 4 weeks all the linoleate was replaced by the deuterium-labeled analog and the animals were killed 4 days later. The molar fraction of total 20:4(n-6) in liver, heart, and kidney phospholipids containing deuterium was 33.9, 8.9, and 13.3%, respectively. Second, animals were preconditioned by incorporating either 0.2% of 18:3(n-6), 20:3(n-6), or 20:4(n-6) into the above diet and again after 4 weeks all the linoleate was replaced with the labeled analog. Now the molar fraction of labeled 20:4(n-6) in liver phospholipids from these three groups of animals was reduced from 33.9 to 27.1, 23.9, and 24.1% respectively. In contrast, there was little change in the specific activity of 20:4(n-6) in heart and kidney phospholipids. The third protocol was a direct crossover study in that again unlabeled linoleate was fed during the entire period. Four days prior to killing the unlabeled 18:3(n-6), 20:3(n-6), and 20:4(n-6) were replaced with the deuterium-labeled analogs. The mole % of total esterified 20:4(n-6) in liver phospholipids was now 24.6, 32.0, and 26.2%, respectively. Even though 18:3(n-6), 20:3(n-6), and 20:4(n-6) were all fed at only 20% of the level of 18:2(n-6), it can be calculated that the molar fraction of esterified 20:4(n-6) in liver phospholipids was between 65 to 77% of that found when 18:2(n-6) was the only dietary (n-6) acid as under these conditions 33.9 mol % of the 20:4(n-6) was labeled. Interestingly, when deuterium-labeled 18:3(n-6), 20:3(n-6), or 20:4(n-6) was fed, the specific activity of esterified 20:4(n-6) in kidney and heart phospholipids was always equal to or greater than what was derived from deuterium-labeled 18:2(n-6). The results show that under steady-state dietary conditions, (n-6) dietary fatty acids are processed in different ways by liver, heart, and kidney.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8558078

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

1.  Cholesteryl ester acyl oxidation and remodeling in murine macrophages: formation of oxidized phosphatidylcholine.

Authors:  Patrick M Hutchins; Robert C Murphy
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

2.  Electrospray MS/MS reveals extensive and nonspecific oxidation of cholesterol esters in human peripheral vascular lesions.

Authors:  Patrick M Hutchins; Ernest E Moore; Robert C Murphy
Journal:  J Lipid Res       Date:  2011-08-31       Impact factor: 5.922

3.  Regulation of the biosynthesis of 4,7,10,13,16-docosapentaenoic acid.

Authors:  B S Mohammed; D L Luthria; S P Bakousheva; H Sprecher
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  The effect of conjugated linoleic acid isomers on fatty acid profiles of liver and adipose tissues and their conversion to isomers of 16:2 and 18:3 conjugated fatty acids in rats.

Authors:  J L Sébédio; E Angioni; J M Chardigny; S Grégoire; P Juanéda; O Berdeaux
Journal:  Lipids       Date:  2001-06       Impact factor: 1.880

5.  Influence of formulas with borage oil or borage oil plus fish oil on the arachidonic acid status in premature infants.

Authors:  H Demmelmair; F Feldl; I Horváth; T Niederland; V Ruszinkó; D Raederstorff; C De Min; R Muggli; B Koletzko
Journal:  Lipids       Date:  2001-06       Impact factor: 1.880

Review 6.  Neonatal polyunsaturated fatty acid metabolism.

Authors:  S M Innis; H Sprecher; D Hachey; J Edmond; R E Anderson
Journal:  Lipids       Date:  1999-02       Impact factor: 1.880

7.  Effect of dietary arachidonic acid on metabolism of deuterated linoleic acid by adult male subjects.

Authors:  E A Emken; R O Adlof; S M Duval; G J Nelson
Journal:  Lipids       Date:  1998-05       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.